Enveda Therapeutics, Inc.

Boulder, CO · Founded 2019 · CIK 0001821392 · Biotech · Private

AI-powered drug discovery platform using natural product chemistry and machine learning to identify therapeutic compounds

enveda.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$67M
2 Form D · Mar 2023
43 months since last filing
Contracts
—
No federal contracts on record
Patents
24
0 granted · 24 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$4,999,998
Private capital raisedForm D · SEC$62,459,761
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2019Outer Biosciences, LLC—$4.0M
2020VITAKEY, INC.—$44M
2021SOMATOCEUTICS, LLC——
2022Enveda Therapeutics, Inc.—$67M
2023Vigil Neuroscience—$195M
2024Sedare Biosciences, Inc.—$2.5M
2025Sentonix, Inc.—$18M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 6 related persons
  • Bruce BeutelDirector
  • Viswa ColluruDirector · Executive Officer
  • Zavain DarDirector
  • Rohit SharmaDirector
  • Shaquille VaydaDirector
  • Daniel WeeExecutive Officer

Patents

USPTO · 0 granted of 24
  • Methods And Systems For Identifying Compounds For Forming, Stabilizing Or Disrupting Molecular Complexesapplication
  • Predicting Chemical Structure And Properties Based On Mass Spectraapplication
  • Isoandrographolide Analogs And Method For Treatment Using The Sameapplication
  • Mass-targeted Fractionation System With Asynchronous Dual-dimension Separationapplication
  • Methods For Identifying Metabolites, And For Developing And Evaluating Therapeutic Agents Based On The Sameapplication
  • Multi-omic Patient Stratification In Inflammatory Bowel Disease Treatmentapplication
  • Methods And Compounds For Modulating Immune Responseapplication
  • Methods And Compounds For Modulating Immune Responseapplication
  • Compounds, Compositions, And Methods For The Treatment Of Metabolic Diseaseapplication
  • Withaferin A Analog And Method For Treatment Using The Sameapplication
  • Mass-targeted Fractionation System With Asynchronous Dual-dimension Separationapplication
  • Multi-omic Patient Stratification In Inflammatory Bowel Disease Treatmentapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.